The effect of ursodeoxycholic acid on liver regeneration after partial hepatectomy in rats with non-alcoholic fatty liver disease

Hepatology Research

Volumn 39, Issue 8, 2009, Pages 814-821

  Uzun, Mehmet Ali ^a,c   Koksal, Neset ^a   Aktas, Suat ^a   Gunerhan, Yusuf ^a   Kadioglu, Huseyin ^a   Dursun, Nevra ^b   Sehirli, Ahmet Ozer ^b  

^a GATA HAYDARPASA TRAINING HOSPITAL   (Turkey)

^b MARMARA UNIVERSITY   (Turkey)

^c NONE   (Turkey)

Author keywords

Fatty liver; Liver regeneration; Oxidative stress; Ursodeoxycholic acid

Indexed keywords

CYCLINE; GLUTATHIONE; MALONALDEHYDE; URSODEOXYCHOLIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ASSAY; CONTROLLED STUDY; DISEASE SEVERITY; EVENING DOSAGE; LIVER REGENERATION; LIVER RESECTION; MALE; MITOSIS INDEX; MORNING DOSAGE; NONALCOHOLIC FATTY LIVER; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; TISSUE LEVEL;

EID: 68349131532     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2009.00511.x     Document Type: Article

References (35)

1. Sanyal AJ. American Gastroenterological Association: AGA technical review on nonalcoholic fatty liver disease. Gastroenterology 2002; 123: 1705-25.
2. Angulo P, Lindor KD. Non-alcoholic fatty liver disease. J Gastroenterol Hepatol 2002; 17: 186-90.
3. Selzner M, Clavien PA. Fatty liver in liver transplantation and surgery. Semin Liver Dis 2001; 21: 105-13.
4. Behrns KE, Tsiotos GG, DeSouza NF, Krishna MK, Ludwig J, Nagorney DM. Hepatic steatosis as a potential risk factor for major hepatic resection. J Gastrointest Surg 1998; 2: 292-98.
5. Marsman WA, Wiesner RH, Rodriguez L et al. Use of fatty donor liver is associated with diminished early patient and graft survival. Transplantation 1996; 62: 1246-51.
6. Veteläinen R, van Vliet AK, van Gulik TM. Severe steatosis increases hepatocellular injury and impairs liver regeneration in a rat model of partial hepatectomy. Ann Surg 2007; 245: 44-50.
7. Adams LA, Angulo P, Lindor KD. Nonalcoholic fatty liver disease. CMAJ 2005; 172: 899-905.
8. Adams LA, Angulo P. Treatment of non-alcoholic fatty liver disease. Postgrad Med J 2006; 82: 315-22.
9. Koniaris LG, Mckillop LH, Schwartz SI, Zimmers TA. Liver regeneration. J Am Coll Surg 2003; 197: 634-59.
10. Higgins GM, Anderson RM. Experimental pathology of the liver: restoration of the liver of a white rat following surgical removal. Arch Pathol 1931; 12: 186-206.
11. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions. Am J Gastroenterol 1999; 94: 2467-74.
12. Aono T, Sakaguchi T, Nakadaira K, Ohtake M, Muto T. Orally administered prostaglandin E1 derivative can enhance liver regeneration in partially hepatectomized rats. Biochem Pharmacol 1993; 46: 767-69.
13. Beutler E. Glutathione in Red Blood Cell Metabolism. A Manual of Biochemical Methods. New York: Grune & Stratton, 1975; 112-14.
14. Buege JA, Aust SD. Microsomal lipid peroxidation. Methods Enzymol 1978; 52: 302-10.
15. Ohara K. Study of microcirculatory changes in experimental dietary fatty liver. Hokkaido Igaku Zasshi 1989; 64: 177-85.
16. Hui AM, Kawasaki S, Makuuchi M, Nakayama J, Ikegami T, Miyagawa S. Liver injury following normothermic ischemia in steatotic rat liver. Hepatology 1994; 20: 1287-93.
17. Fromenty B, Pessayre D. Impaired mitochondrial function in microvesicular steatosis. Effects of drugs, ethanol, hormones and cytokines. J Hepatol 1997; 26: 43-53.
18. Selzner M, Claiven PA. Failure of regeneration of the steatotic rat liver: Disruption at two different levels in the regeneration pathway. Hepatology 2000; 31: 35-42.
19. Ishizaki K, Imada T, Tsurufuji M. Hepatoprotective bile acid "ursodeoxycholic acid (UDCA)" property and difference as bile acids. Hepatol Res 2005; 33: 174-7.
20. Invernizzi P, Setchell KD, Crosignani A et al. Differences in the metabolism and disposition of ursodeoxycholic acid and of its taurine-conjugated species in patients with primary biliary cirrhosis. Hepatology 1999; 29: 320-7.
21. Barone M, Francavilla A, Polimeno L et al. Modulation of rat hepatocyte proliferation by bile salts: In vitro and in vivo studies. Hepatology 1996; 23: 1159-66.
22. Liu L, Sakaguchi T, Cui X, Shirai Y, Nishimaki T, Hatakeyama K. Liver regeneration enhanced by orally administered ursodeoxycholic acid is mediated by immunosuppression in partially hepatectomized rats. Am J Chin Med 2002; 30: 119-26.
23. Sakaguchi T, Liu L. Hepatic branch vagotomy can block liver regeneration enhanced by ursodeoxycholic acid in 66% hepatectomized rats. Auton Neurosci 2002; 99: 54-7.
24. Angulo P. Use of ursodeoxycholic acid in patients with liver disease. Curr Gastroenterol Rep 2002; 4: 37-44.
25. Okada K, Shoda J, Taguchi K et al. Ursodeoxycholic acid stimulates Nrf2-mediated hepatocellular transport, detoxification, and antioxidative stress systems in mice. Am J Physiol Gastrointest Liver Physiol 2008; 295: 735-47.
26. Laurin J, Lindor KD, Crippen JS et al. Ursodeoxycholic acid or clofibrat in the treatment of non-alcohol-induced steatohepatitis: A pilot study. Hepatology 1996; 23: 1464-7.
27. Lindor KD, Kowdley KV, Heathcote EJ et al. Ursodeoxycholic acid for treatment of nonalcoholic steatohepatitis: Results of a randomized trial. Hepatology 2004; 39: 770-8.
28. Shronts EP. The role of choline in parenteral nutrition induced liver dysfunction. Rev Bras Nutr Clin 1997; 12: 41-8.
29. Yao ZM, Vance DE. The active synthesis of phosphatidylcholine is required for very low density lipoprotein secretion from rat hepatocytes. J Biol Chem 1988; 263: 2998-3004.
30. Gawrieh S, Opara EC, Koch TR. Oxidative stress in nonalcoholic fatty liver disease: Pathogenesis and antioxidant therapies. J Investig Med 2004; 52: 506-14.
31. Rodríguez-Ortigosa CM, Cincu RN, Sanz S, Ruiz F, Quiroga J, Prieto J. Effect of ursodeoxycholic acid on methionine adenosyltransferase activity and hepatic glutathione metabolism in rats. Gut 2002; 50: 701-6.
32. Ozden TA, Uzun H, Bohloli M et al. The effects of hyperbaric oxygen treatment on oxidant and antioxidants levels during liver regeneration in rats. Tohoku J Exp Med 2004; 203: 253-65.
33. Huang ZZ, Li H, Cai J, Kuhlenkamp J, Kaplowitz N, Lu SC. Changes in glutathione homeostasis during liver regeneration in the rat. Hepatology 1998; 27: 147-53.
34. Esterbauer H, Schaur RJ, Zollner H. Chemistry and biochemistry of 4-hidroxinonenal, malondialdehyde and related aldehydes. Free Radic Biol Med 1991; 11: 81-128.
35. Albano E, Mottaran E, Vidali M et al. Immune response towards lipid peroxidation products as a predictor of progression of non-alcoholic fatty liver disease to advanced fibrosis. Gut 2005; 54: 987-93.